Search

everythinglearnresearchcommunity

for

Search:↓

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

The Persian cat has a skin infection caused by a fungus, treatable with antifungal medication.

Applying latanoprost on skin can stimulate hair growth with minimal side effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Minoxidil foam promotes hair growth and reduces hair loss safely in men.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

People undergoing chemotherapy need better support and information to cope with hair loss.

Eating less can slow aging and help keep stem cells healthy by cleaning out damaged cell parts.

Non-immune factors play a significant role in alopecia areata.